Carolina Venditti has experience in basic and diagnostic microbiology as well as on emerging infectious diseases, molecular biology and whole genome sequencing (WGS) of Gram-negative and - positive pathogens. Her research activities are on detection of novel mechanisms of resistance and study of plasmid content on carbapenem-resistant Enterobacterales (CRE). She is also involved in outbreak investigations of nosocomial infections. Currently her studies are on the characterization of CRE exhibiting resistance to ceftazidime-avibactam.